Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Finally, interim data presented at SITC from Dr. Steven Lin's Phase 2 study suggests that NKTR-255 has the potential to confer clinical benefits in patients with locally advanced non-small-cell ...

After hours: March 13 at 7:48:27 PM EDT Loading Chart for LIN ...

After hours: March 10 at 7:51:24 PM EDT ...

Ulcerative colitis (UC) is an incurable autoimmune disease. Patients with UC endure the burden of recurrent flare-ups and face a substantial economic burden due to long-term medication. The complex ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment ...